CARI Health
San Diego, US · Founded 2021 · Delaware corporation · 1 known investors
CARI Health develops a clinical testing platform that delivers rapid methadone concentration and metabolic data to clinicians at the point of care, enabling personalized dosing for opioid use disorder treatment. The platform helps reduce under- and over-dosing risks by providing data on patient metabolizer status (slow vs. fast) to improve treatment outcomes.
Founders & leadership
PS
Patrik SchmidleNamed on SEC filing
Board
GM
Gioia MessingerBoard director
CP
Charles PattonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 4 rounds · 2022–2025
▶$100KraisedJul 2025 · 2 investors · BiotechnologyRule 506(b)
▶$100KraisedJul 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrik SchmidleExecutive Officer, Director
- Charles PattonDirector
- Gioia MessingerDirector
- Offering amount
- $1M
- Amount sold
- $100K
- Minimum investment
- $25K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$150KraisedFeb 2024 · 2 investors · BiotechnologyRule 506(b)
▶$150KraisedFeb 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles PattonDirector
- Patrik SchmidleExecutive Officer, Director
- Gioia MessingerDirector
- Offering amount
- $3M
- Amount sold
- $150K
- Minimum investment
- $50K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.3MraisedFeb 2024 · 11 investors · BiotechnologyRule 506(b)
▶$2.3MraisedFeb 2024 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gioia MessingerDirector
- Patrik SchmidleExecutive Officer, Director
- Charles PattonDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- Minimum investment
- $50K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$800KraisedMay 2022 · 4 investors · BiotechnologyRule 506(b)
▶$800KraisedMay 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrik SchmidleExecutive Officer, Director
- Gioia MessingerDirector
- Charles PattonDirector
- Offering amount
- $2.2M
- Amount sold
- $800K
- Minimum investment
- $100K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapCary Health13 shared keywordsCary Health provides digital healthcare software, offering fulfillment and hub services for pharmaceutical manufacturers and AI-based tools to help clinical teams at health systems work more efficiently.
Israel Israel Israel11 shared keywordsK Health provides an agentic clinical AI platform for health systems, offering symptom investigation, patient triage, and automated documentation integrated into Epic and MyChart. It supports fully integrated primary care through consumer intake tools, provider-facing workflow support, and a 24/7 virtual clinic staffed by credentialed providers, serving U.S. health systems.
Keona Health8 shared keywords
Clara Health7 shared keywordsClara Health operates a decentralized clinical trial platform that connects patients with clinical studies and provides 24/7 patient navigators to guide them through matching, scheduling, insurance, and paperwork at no cost. It also helps trial sponsors reach diverse and representative patient populations beyond physical trial sites; the company has been acquired by clinical research organization M&B Sciences Inc.
Curative6 shared keywordsCurative offers an employer-sponsored health insurance plan with $0 copays, $0 deductibles, and a single monthly premium, giving members access to a nationwide provider network, telehealth, and $0 preferred prescriptions. The plan includes a cash card for out-of-pocket-free care and support from care navigators to help members manage their health.
Curaihealth6 shared keywordsCurai Health offers virtual primary care through a chat-based service, connecting patients with a care team of medical experts for diagnosis, treatment, prescription renewals, and management of conditions such as flu, hypertension, and diabetes. It serves individuals with or without insurance for a monthly fee paid by the patient or their employer.
Clarium6 shared keywordsClarium provides an AI-powered platform that automates hospital operational and administrative workflows, including supply chain and demand planning functions. The platform surfaces high-complexity issues to healthcare providers while automating routine tasks across their data ecosystem.
Companies competing with CARI Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does CARI Health do?
- CARI Health develops a clinical testing platform that delivers rapid methadone concentration and metabolic data to clinicians at the point of care, enabling personalized dosing for opioid use disorder treatment. The platform helps reduce under- and over-dosing risks by providing data on patient metabolizer status (slow vs. fast) to improve treatment outcomes.
- Who are CARI Health's investors?
- CARI Health's investors include Cove Fund.
- How much funding has CARI Health raised?
- CARI Health has disclosed $3.4M raised across 4 rounds.
- Where is CARI Health headquartered?
- CARI Health is headquartered in San Diego, US.